​​​

News

Get the latest news from Rigshospitalet.
210 news stories
1-50 | 51-100 | 101-150 | 151-200 | 201-210 | >

Danish corona research could improve vaccination techniques

​Ground-breaking research from Copenhagen University Hospital – Rigshospitalet and Herlev and Gentofte Hospital has shed new light on the immune system’s complex struggle against the coronavirus.

Data from olaparib treated patients across histologies presented at Danske Kræftforskningsdage 2023

First surgical 'Nobel Prize' goes to Danish Professor

​​Professor Henrik Kehlet from Copenhagen University Hospital - Rigshospitalet​ recei​ves a new, prestigious award ​in surgery for his lifelong work on patient care and Enhanced Recovery After Surgery(ERAS).

New study: a plant-based diet has an effect on your cholesterol level

​The hitherto largest study to investigate the effect of vegetarian and vegan diets shows that it is possible to reduce ‘bad’ cholesterol levels by up to 14 per cent by eating plant-based foods. A plant-based diet throughout life can reduce the risk of blood clots in the heart considerably.

More cancer patients can escape chemotherapy

​A paradigm shift is on the way in the treatment of chronic lymphatic leukaemia (CLL). From now on, targeted treatment could replace chemotherapy for most of the patients, according to new research.

DNA screening can save lives – new Danish method makes it 20-times cheaper

​Researchers have found the world’s cheapest method of screening large groups of people for rare genetic diseases. The method is now being tested in a large research project with support totalling DKK 36.7 mill. from Innovation Fund Denmark, Børnecancerfonden and the Novo Nordisk Foundation​

Stem cells give cancer patients their saliva back

Many people with cancer suffer damage to their salivary glands as a side effect of radiation therapy. Researchers from Copenhagen University Hospital - Rigshospitalet now hope to be able to restore patients’ saliva function with a promising stem cell treatment.

New project to measure Alzheimer's and Parkinson's via the ear

​Serious brain diseases such as Alzheimer's and Parkinson's are usually diagnosed too late for optimal benefit from available drug and non-drug treatments. A new research project will develop and test a scalable home health care technology that could have a major impact on early detection, diagnosis, prevention and treatment of both diseases.

Presentation at European Lung Cancer Congress

​Martin Højgaard presented data under the title “Efficacy and ctDNA analysis in an updated cohort of patients with TRK fusion lung cancer treated with Larotrectinib” at European Lung Cancer Congress (ELCC)

New germline pathogenic variants identified in mesothelioma patients

​A newly published study revealed a high frequency of germline pathogenic variants in patients with mesothelioma including variants in two genes not previously associated with mesothelioma. The data support germline testing in these patients to identify potential actionable targets and genetic counseling.​​

Immunotherapy for endometrial cancer shows impressive results

​Far fewer died or experienced a deterioration in their endometrial cancer after receiving a new immunotherapy treatment as well as chemotherapy in an extensive trial. The researchers assess that the treatment could mean a full recovery for some patients with primary advanced or recurrent endometrial cancer.

Breakthrough: Newborns with spinal muscular atrophy can lead a normal life

A new screening process for newborns has found the first children with the disabling disease: spinal muscular atrophy (SMA). Early treatment can mean that many infants will never develop symptoms.

Researchers investigate the effect of sleep extension in children

​Many children and young people sleep less than recommended. With a donation from the Novo Nordisk Research Foundation, researchers from University of Copenhagen and Copenhagen University Hospital - Rigshospitalet will study the effect of sleep extension on weight, metabolism and learning in 6–9-year-old children.

Intestinal bacteria may be an important piece in the jigsaw puzzle of multiple sclerosis

​Findings of bacteria with anti-inflammatory effects in the intestines of sclerosis patients with no evidence of active disease indicate that diet, bacteria and disease progression are linked.

Associate professor Faisal Mohammad Amin will investigate and provide novel data on functional features of the migraine brain

This is to reveal migraine-specific biomarkers. The project will also reveal if migraine-specific drugs modulate brain dysfunction.

Australian professor honoured after long collaboration

This year, the international KFJ Award goes to Professor Mark Febbraio, who has been working with Copenhagen University Hospital - Rigshospitalet on research into the effect of physical activity on the immune system for more than two decades.

Gene therapy tested against muscular dystrophy

​The first patient with a specific type of muscular dystrophy has been treated using gene therapy. It is hoped the therapy will halt the disease. ​

Blood from donors of the same sex increases survival rates

Survival rates increase if patients undergoing a blood transfusion receive blood from a donor of the same sex, according to sensational new research from Rigshospitalet.

Patients with blood poisoning do not have to take so much fluid

Halving fluids to treat intensive-care patients with blood poisoning causes neither higher mortality nor more serious side effects according to a new trial. ​

Cornerstone laid for Mary Elizabeth’s Hospital

Her Royal Highness Crown Princess Mary has laid the cornerstone for Rigshospitalet's new hospital for children, teens, expecting mothers and their families. Mary Elizabeth’s Hospital - Rigshospitalet for Children, Teens and Expecting Families will be a pioneering hospital in which life abounds on the patients’ terms.

New brain-haemorrhage treatment tested on patients for the first time

Researchers from Rigshospitalet have launched first-in-human trials of a groundbreaking new treatment principle for brain haemorrhages. The professor behind the trials has been working on this breakthrough for 25 years, and he is now about to embark on the second treatment breakthrough in his career. ​​​

Good results with surgery for malignant pleural mesothelioma

All the malignant pleural mesothelioma operations in Denmark are performed by just a small group of experts. This has led to large improvements in the survival rate for a disease that was untreatable 20 years ago.​

Alzheimer’s Disease: The Identification of 75 Genetic Risk Factors Brings New Insights

Researchers in Europe, the US and Australia have identified 75 regions of the genome that are associated with Alzheimer's disease. Forty-two of these regions are novel, meaning that they have never before been implicated in the disease.​​

Paracetamol can impair men’s ability to make women pregnant

New research has disconcerting news: Large quantities of paracetamol seem to affect the function of sperm cells and possibly men’s ability to make women pregnant.​

Best in the world to detect cancer mutations

The Center for Genomic Medicine has been awarded the gold medal in genetic variant detection from genomic data in cancer diagnostics. The challenge was organised by the American Food and Drug Administration (FDA) and counted participants from throughout the world.

Gene researchers can now explain different types of migraine

The world's largest gene study on migraine describes, for the first time, the genetic differences between migraine with and without aura. The results look promising for developing new medicines, says the Danish co-author.​

BørneRiget to have royal new name

​Rigshospitalet's new hospital for children, young people, expecting mothers and their families will be named after Her Royal Highness Crown Princess Mary. The hospital is to open in four years, and it will be called ‘Mary Elizabeth’s Hospital - Rigshospitalet for Children, Teens and Expecting Families´.

Not all patients with COVID-19 need the same medicine

​Some patients with COVID pneumonia benefit from antibody medicine to combat the virus. For others, this is no help at all - and perhaps it has the opposite effect.

​ Chemicals and fossil fuels could be behind falling birth rates

​Alarming new international study published in the prestigious journal Nature Reviews Endocrinology.

Well-known drug could help the most severely affected Covid-19 patients in intensive-care departments

​Damage to the body's most important organs is reduced significantly in mechanically ventilated patients with corona if they receive a medicine called prostacyclin. This is the result of a new study from Rigshospitalet.

French intensive care physician receives this year's international KFJ Award

Professor Elie Azoulay has received Rigshospitalet's international KFJ Award for his ground-breaking research on some of the most seriously ill intensive care patients with blood cancer.

Expert group: pregnant women should be wary of taking paracetamol

​Pain-relieving medication with paracetamol should not be taken during pregnancy unless there are good medical reasons for doing so, and only at the lowest possible dosage.

Scottish professor wins prestigious Danish research award

The International KFJ research award from Copenhagen University Hospital – Rigshospitalet goes to professor John McMurray from the University of Glasgow. The Scottish research heavyweight has been working with Danish heart failure researchers for more than a decade.

Scottish specialist in the heart failure wins prestigious Danish award

Rigshospitalet's international KFJ Award goes to Professor John McMurray from the University of Glasgow. The Scottish research heavyweight has been working with Danish heart researchers for more than ten years.

Men with testicular cancer stand a good chance of having children

​A new study from Rigshospitalet shows that men with testicular cancer have a far better chance of obtaining fatherhood after treatment than previously assumed. In fact, statistically around half of all men who have undergone treatment for testicular cancer have the same chance of obtaining fatherhood as the rest of the male population.

A tiny gene mutation with a huge significance for male sperm production

New research from Rigshospitalet explains why some men produce no sperm cells at all, meaning that fertility treatment can never help them.

Researchers link drug with higher risk of tumours in the brain membrane

​A new study from Rigshospitalet has demonstrated a link between the drug cyproterone acetate (Androcur®) and a type of brain tumour known as a meningioma. Among other things, the drug is used for male-to-female transgender hormone therapy.

Danish-Norwegian registry study on adverse reactions after AstraZeneca vaccination has now been published

​In a Danish-Norwegian collaboration, researchers have shown a slightly increased rate of rare but serious types of cerebral blood clots as well as a generally increased rate of venous blood clots following vaccination with the AstraZeneca vaccine. The risk of such adverse events is considered very low for the individual vaccine recipient.

Research breakthrough provides hope for a new treatment for men with low sperm quality

Researchers at Rigshospitalet and Harvard University are the first in the world to prove that a drug against osteoporosis also increases the number of sperm cells in men with low sperm quality. There is hope the drug can be used in a new, promising treatment for men with low sperm quality.

New research: Considerably lower incidence of cervical cancer for young women vaccinated against HPV

​A major Danish study has showed that the incidence of cervical cancer is up to 86% lower for women who received HPV vaccine before the age of 20. The researchers behind the study believe that it may be possible to almost eradicate cervical cancer in Denmark.

Rigshospitalet launches pitching tool for healthcare solutions

Rigshospitalet is now making it easier for companies and start-ups to pitch innovative health- and care solutions with a new on-line “Pitch –and-match” tool. The aim of the tool is to match innovative ideas and technologies from start-ups to clinics with specific needs.

Migraine pioneers receive world’s most prestigious brain research prize

​Professors Jes Olesen and Lars Edvinsson from Rigshospitalet and the University of Copenhagen receive the most prestigious brain research prize in the world, the Lundbeck Foundation Brain Prize, which they will be the first researchers in the Nordic countries to receive. The prize celebrates 40 years of research into migraine, which is now recognised as a treatable neurological disease.

Computer can determine whether you’ll die from COVID

​Using patient data, artificial intelligence can make a 90 percent accurate assessment of whether a person will die from COVID-19 or not. Now Danish hospitals will use the data to predict how many patients will need a respirator 5 days later.

Global COVID-19 study comes with rapid results on first antibody

The first treatment results from a worldwide COVID-19 study show that treatment with the antibody LY-CoV555 has no effect on patients in hospital. Three new antibodies now to be tested.

Denmark trial measures effectiveness of adding a mask recommendation to other public health measures for preventing SARS-CoV-2 infection

​​A randomized trial of more than 6,000 participants in Denmark adds new evidence to what is known about whether masks protect the wearer from SARS-CoV-2 infection.

Rigshospitalet tests a black box in an operating room

​Can a black box in operating rooms increase patient safety and reduce disruptions? This is now being tested in a new research and development project at Rigshospitalet.

Healthy Lifestyle Cuts the Risk of Dementia in Half

​New research shows that a healthy cardiovascular lifestyle almost cuts the risk of age-related dementia in half. The results open up the possibility that cardiovascular disease and dementia can be prevented simultaneously.

A unique Danish Covid-19 study presents its data

​What happened to Covid-19 patients in Danish intensive-care departments during the first wave of Corona in the spring

Large increase in HPV-related head and neck cancer in Denmark

New research from Rigshospitalet shows that there has been a threefold increase in HPV-related oropharyngeal cancer cases over the past 18 years.

Specially designed virtual reality game for children who are afraid of needles

The Paediatric Pain Knowledge Centre at Rigshospitalet and the virtual reality (VR) company Khora have developed a specially designed VR game that can help children sit still, for example while blood samples are being taking, and distract them from the needle and the pain.
210 news stories
1-50 | 51-100 | 101-150 | 151-200 | 201-210 | >
Responsible editor
Webgruppen på Rigshospitalet